Creative Medical Technology (CELZ) Competitors $2.33 +0.06 (+2.64%) As of 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CELZ vs. NKGN, CING, NERV, SPRB, ACXP, NRSN, PRPH, HCWB, FLGC, and AIMShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include NKGen Biotech (NKGN), Cingulate (CING), Minerva Neurosciences (NERV), Spruce Biosciences (SPRB), Acurx Pharmaceuticals (ACXP), NeuroSense Therapeutics (NRSN), ProPhase Labs (PRPH), HCW Biologics (HCWB), Flora Growth (FLGC), and AIM ImmunoTech (AIM). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. NKGen Biotech Cingulate Minerva Neurosciences Spruce Biosciences Acurx Pharmaceuticals NeuroSense Therapeutics ProPhase Labs HCW Biologics Flora Growth AIM ImmunoTech NKGen Biotech (NYSE:NKGN) and Creative Medical Technology (NASDAQ:CELZ) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, valuation, profitability, dividends, risk, media sentiment and institutional ownership. Do institutionals and insiders hold more shares of NKGN or CELZ? 76.2% of NKGen Biotech shares are held by institutional investors. Comparatively, 1.4% of Creative Medical Technology shares are held by institutional investors. 74.7% of NKGen Biotech shares are held by insiders. Comparatively, 2.8% of Creative Medical Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, NKGN or CELZ? NKGen Biotech has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, Creative Medical Technology has a beta of 1.78, suggesting that its stock price is 78% more volatile than the S&P 500. Is NKGN or CELZ more profitable? NKGen Biotech's return on equity of 0.00% beat Creative Medical Technology's return on equity.Company Net Margins Return on Equity Return on Assets NKGen BiotechN/A N/A -479.36% Creative Medical Technology N/A -63.05%-60.42% Does the media prefer NKGN or CELZ? In the previous week, NKGen Biotech's average media sentiment score of 0.00 equaled Creative Medical Technology'saverage media sentiment score. Company Overall Sentiment NKGen Biotech Neutral Creative Medical Technology Neutral Which has better valuation and earnings, NKGN or CELZ? Creative Medical Technology has lower revenue, but higher earnings than NKGen Biotech. Creative Medical Technology is trading at a lower price-to-earnings ratio than NKGen Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNKGen Biotech$80K212.97-$82.94M-$5.08-0.09Creative Medical Technology$10K407.75-$5.29M-$3.80-0.61 Does the MarketBeat Community believe in NKGN or CELZ? Creative Medical Technology received 71 more outperform votes than NKGen Biotech when rated by MarketBeat users. CompanyUnderperformOutperformNKGen BiotechN/AN/ACreative Medical TechnologyOutperform Votes7168.93% Underperform Votes3231.07% SummaryCreative Medical Technology beats NKGen Biotech on 6 of the 11 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.08M$3.01B$5.39B$9.13BDividend YieldN/A1.89%5.37%4.00%P/E Ratio-0.6146.0188.8317.53Price / Sales407.75291.451,282.2680.28Price / CashN/A189.5236.6032.90Price / Book0.314.004.964.69Net Income-$5.29M-$40.99M$117.89M$224.57M7 Day Performance8.37%3.23%2.75%3.33%1 Month Performance12.56%0.60%3.63%5.33%1 Year Performance-44.92%-0.09%27.27%22.97% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical TechnologyN/A$2.33+2.6%N/A-46.3%$4.08M$10,000.00-0.615Positive NewsGap UpNKGNNKGen BiotechN/A$0.44-4.4%N/A-83.3%$15.57M$80,000.00-0.09N/ACINGCingulate2.4404 of 5 stars$4.76-4.4%$12.00+152.1%+5.3%$15.28MN/A0.0020NERVMinerva Neurosciences3.3536 of 5 stars$2.17+0.7%$5.00+130.9%-71.2%$15.13MN/A-4.929Analyst ForecastNews CoverageGap DownSPRBSpruce Biosciences4.0286 of 5 stars$0.36-4.8%$3.90+969.1%-84.7%$15.07M$10.09M-0.3920Positive NewsACXPAcurx Pharmaceuticals3.033 of 5 stars$0.88+12.2%$12.00+1,259.0%-76.1%$15.04MN/A-0.813Short Interest ↓High Trading VolumeNRSNNeuroSense Therapeutics0.7102 of 5 stars$1.09-2.7%N/A+13.5%$14.90MN/A-1.7010PRPHProPhase Labs3.3838 of 5 stars$0.60-0.8%$11.00+1,747.8%-88.0%$14.21M$44.38M-0.47130HCWBHCW Biologics1.6141 of 5 stars$0.37+3.2%N/A-66.4%$13.99M$2.84M-0.3740FLGCFlora Growth2.1717 of 5 stars$0.96+3.2%$5.00+420.9%-43.5%$13.85M$76.07M0.00280Positive NewsAIMAIM ImmunoTech1.8527 of 5 stars$0.21+8.4%$2.75+1,186.2%-49.1%$13.64M$200,000.00-0.4520 Related Companies and Tools Related Companies NKGen Biotech Alternatives Cingulate Alternatives Minerva Neurosciences Alternatives Spruce Biosciences Alternatives Acurx Pharmaceuticals Alternatives NeuroSense Therapeutics Alternatives ProPhase Labs Alternatives HCW Biologics Alternatives Flora Growth Alternatives AIM ImmunoTech Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CELZ) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CELZ Stock Alerts